» Articles » PMID: 37466172

Learning Curve of Lung Dose Optimization in Intensity-modulated Radiotherapy for Locally Advanced Non-small Cell Lung Cancer

Overview
Journal Thorac Cancer
Date 2023 Jul 19
PMID 37466172
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Intensity-modulated radiotherapy (IMRT) has been increasingly used for patients with locally advanced non-small cell lung cancer (LA-NSCLC). However, there are some barriers to implementing IMRT for LA-NSCLC, including the complexity of treatment plan optimization. This study aimed to evaluate the learning curve of lung dose optimization in IMRT for LA-NSCLC and identify the factors that affect the degree of achievement of lung dose optimization.

Methods: We retrospectively evaluated 40 consecutive patients with LA-NSCLC who received concurrent chemoradiotherapy at our institution. These 40 patients were divided into two groups: 20 initially treated patients (earlier group) and 20 subsequently treated patients (later group). Patient and tumor characteristics were compared between the two groups. The dose-volume parameter ratio between the actually delivered IMRT plan and the simulated three-dimensional conformal radiotherapy plan was also compared between the two groups to determine the learning curve of lung dose optimization.

Results: The dose-volume parameter ratio for lung volume to receive more than 5 Gy (lung V5) and mean lung dose (MLD) significantly decreased in later groups. The spread of the beam path and insufficient optimization of dose coverage of planning target volume (PTV) might cause poor control of lung V5, MLD.

Conclusions: A learning curve for lung dose optimization was observed with the accumulation of experience. Appropriate techniques, such as restricting the beam path and ensuring dose coverage of PTV during the optimization process, are essential to control lung dose in IMRT for LA-NSCLC.

Citing Articles

Treatment time and learning curve analysis of 1.5 T MR-Linac workflows led by radiation oncologists or therapists.

Westerhoff J, Raaijmakers F, Daamen L, de Groot-van Breugel E, Meijers L, van der Voort van Zyp J Clin Transl Radiat Oncol. 2025; 51:100901.

PMID: 39867726 PMC: 11759539. DOI: 10.1016/j.ctro.2024.100901.


Effects of Institutional Experience on Plan Quality in Stereotactic Radiotherapy Using HyperArc for Brain Metastases.

Kihara S, Ohira S, Kanayama N, Ikawa T, Inui S, Isono M In Vivo. 2024; 39(1):210-217.

PMID: 39740907 PMC: 11705131. DOI: 10.21873/invivo.13819.


Learning curve of lung dose optimization in intensity-modulated radiotherapy for locally advanced non-small cell lung cancer.

Igari M, Abe T, Iino M, Saito S, Aoshika T, Ryuno Y Thorac Cancer. 2023; 14(26):2642-2647.

PMID: 37466172 PMC: 10493474. DOI: 10.1111/1759-7714.15046.

References
1.
Staffurth J . A review of the clinical evidence for intensity-modulated radiotherapy. Clin Oncol (R Coll Radiol). 2010; 22(8):643-57. DOI: 10.1016/j.clon.2010.06.013. View

2.
Mayahara H, Uehara K, Harada A, Kitatani K, Yabuuchi T, Miyazaki S . Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancer. Radiat Oncol. 2022; 17(1):7. PMC: 8760798. DOI: 10.1186/s13014-021-01979-z. View

3.
Igari M, Abe T, Iino M, Saito S, Aoshika T, Ryuno Y . Learning curve of lung dose optimization in intensity-modulated radiotherapy for locally advanced non-small cell lung cancer. Thorac Cancer. 2023; 14(26):2642-2647. PMC: 10493474. DOI: 10.1111/1759-7714.15046. View

4.
Fleckenstein J, Kremp K, Kremp S, Palm J, Rube C . IMRT and 3D conformal radiotherapy with or without elective nodal irradiation in locally advanced NSCLC: A direct comparison of PET-based treatment planning. Strahlenther Onkol. 2015; 192(2):75-82. DOI: 10.1007/s00066-015-0900-9. View

5.
Abe T, Iino M, Saito S, Aoshika T, Ryuno Y, Ohta T . Simple method for evaluating achievement degree of lung dose optimization in individual patients with locally advanced non-small cell lung cancer treated with intensity modulated radiotherapy. Thorac Cancer. 2022; 13(20):2890-2896. PMC: 9575059. DOI: 10.1111/1759-7714.14634. View